🇺🇸 Transamine in United States

49 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 49

Most-reported reactions

1. Pyrexia — 9 reports (18.37%)
2. White Blood Cell Count Decreased — 7 reports (14.29%)
3. Pneumonia — 6 reports (12.24%)
4. Neutrophil Count Decreased — 5 reports (10.2%)
5. Haemoglobin Decreased — 4 reports (8.16%)
6. Hepatic Function Abnormal — 4 reports (8.16%)
7. Insomnia — 4 reports (8.16%)
8. Platelet Count Decreased — 4 reports (8.16%)
9. Blood Bilirubin Increased — 3 reports (6.12%)
10. Diarrhoea — 3 reports (6.12%)

Source database →

Frequently asked questions

Is Transamine approved in United States?

Transamine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Transamine in United States?

Ankara Etlik City Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.